Items where authors include "Fox, N"

Export as [feed] Atom [feed] RSS
Number of items: 6.

Article

Abani, O, Abbas, A, Abbas, F et al. (6300 more authors) (2022) Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 399 (10325). pp. 665-676. ISSN 0140-6736

Abani, O, Abbas, A, Abbas, F et al. (4809 more authors) (2021) Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. The Lancet, 397 (10289). pp. 2049-2059. ISSN 0140-6736

Abani, O orcid.org/0000-0003-2209-9956, Abbas, A, Abbas, F et al. (6346 more authors) (2021) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 397 (10285). pp. 1637-1645. ISSN 0140-6736

Elson, KM, Fox, N, Tipper, JL et al. (4 more authors) (2015) Non-destructive monitoring of viability in an ex vivo organ culture model of osteochondral tissue. eCells and Materials Journal, 29. 356 - 369. ISSN 1473-2262

Wilson, CL, Jurk, D, Fullard, N et al. (19 more authors) (2015) NFκ B1 is a suppressor of neutrophil-driven hepatocellular carcinoma. Nature Communications, 6. ARTN 6818. ISSN 2041-1723

Proceedings Paper

Fox, N, Stanley, M, Thomas, D orcid.org/0000-0001-5584-9114 et al. (2 more authors) (2016) Development of an Ex-Vivo Organ Culture Model of the Femoral-Tibial Joint. In: Orthopaedic Research Society 2015 Annual Meeting. Orthopaedic Research Society 2015 Annual Meeting, 28-31 Mar 2015, Las Vegas, Nevada. . (Unpublished)

This list was generated on Sat Mar 23 17:02:54 2024 GMT.